Roche Tamiflu Ad Letter Continues FDA Scrutiny Of New Flu Drugs
Executive Summary
Roche's claim that Tamiflu "reduces the duration of the flu" overstates the efficacy of the drug, FDA maintained in an April 14 letter to Roche.
You may also be interested in...
Roche Tamiflu Celebrity Endorsement Ad Challenged By FDA
Celebrity endorsements of prescription drugs must be carefully qualified to avoid overstating efficacy, FDA told Roche in a letter objecting to a radio broadcast commercial for the flu therapy Tamiflu (oseltamivir)
Roche Tamiflu Celebrity Endorsement Ad Challenged By FDA
Celebrity endorsements of prescription drugs must be carefully qualified to avoid overstating efficacy, FDA told Roche in a letter objecting to a radio broadcast commercial for the flu therapy Tamiflu (oseltamivir)
Roche Xenical Patient Compliance Could Increase With New DTC Campaign
Roche will attempt to increase patient compliance for its obesity drug Xenical through a multi-faceted direct-to-consumer campaign.